NEW YORK (360Dx) – T2 Biosystems reported after the close of the market on Thursday that its third quarter revenues jumped 127 percent year over year,

For the three months ended Sept. 30, the company posted revenues of $2.5 million, compared to $1.1 million in the prior-year period, beating the consensus Wall Street estimate of $2.3 million.

Product revenues rose 71 percent to $1.2 million from $739,000 in Q3 2017, and research revenues increased 325 percent to $1.2 million from $369,000 in Q3 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.